Males’ Access to Human Papillomavirus Vaccination in Resource-Limited Settings

References

• IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human Papillomaviruses. Lyon (FR): International Agency for Research on Cancer; 2007. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 90) 1. Available from: https://www.ncbi.nlm.nih.gov/books/NBK321770/. Accessed February 13, 2024.
   Google Scholar
• Meites E, Gee J, Unger E, Markowitz L Human papillomavirus human papillomavirus. 2021. p. 165–178.
   Google Scholar
• Bihl MP, Tornillo L, Kind AB, et al. Human Papillomavirus (HPV) Detection in Cytologic Methodology. Appl Immunohistochem Mol Morphol. 2017;25(3):184–189. doi:10.1097/PAI.0000000000000290
   PubMedGoogle Scholar
• Wiener JS, Effert PJ, Humphrey PA, Yu L, Liu ET, Walther PJ. Prevalence of human papillomavirus types 16 and 18 in squamous-cell carcinoma of the penis: a retrospective analysis of primary and metastatic lesions by differential polymerase chain reaction. Int J Cancer. 1992;50(5):694–701. doi:10.1002/ijc.2910500505
   PubMed Web of Science ®Google Scholar
• wALBooMER MM, Acos MV. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;19:12–19.
   Google Scholar
• Bruni L, Albero G, Serrano B, et al., ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Ethiopia. Summary Report; 2016.
   Google Scholar
• Lewis RM, Markowitz LE, Gargano JW, Steinau M, Unger ER. Prevalence of genital human papillomavirus among sexually experienced males and females aged 14–59 years, United States, 2013–2014. J Infect Dis Dis. 2019;217(6):869–877.
   Web of Science ®Google Scholar
• Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings; 2010:202.
   Google Scholar
• Deshmukh KS, Suk R, Chiao EY, Differences in prevalence between sexes and concordance with genital human papillomavirus infection, NHANES 2011 to 2014. Ann Intern Med. 2018;167(10):714–724.
   Web of Science ®Google Scholar
• HPV and Cancer. Available from: https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer. Accessed February 13, 2024.
   Google Scholar
• Bruni L, Albero G, Rowley J, et al. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis. Lancet Glob Heal. 2023;11(9):e1345–62. doi:10.1016/S2214-109X(23)00305-4
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Ca Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Olesen TB, Munk C, Christensen J, Andersen KK, Kjaer SK. Human papillomavirus prevalence among men in sub-Saharan Africa: a systematic review and meta-analysis. Sex Transm Infect. 2014;3(6):455–462. doi:10.1136/sextrans-2013-051456
   Google Scholar
• World Health Organization. Human Papillomavirus Vaccines: WHO Position Paper (2022 Update) Weekly Epidemiological Record Relevé Épidémiologique Hebdomadaire. Vol. 2020. World Health Organization; 2022:645–672.
   Google Scholar
• Kidd LC, Chaing S, Chipollini J, Giuliano AR, Spiess PE, Sharma P. Relationship between human papillomavirus and penile cancer — implications for prevention and treatment. Transl Androl Urol. 2017;6(5):791–802. doi:10.21037/tau.2017.06.27
   PubMed Web of Science ®Google Scholar
• Patel H, Wagner M, Singhal P, Kothari S. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis. 2013;13(1). doi:10.1186/1471-2334-13-39
   PubMedGoogle Scholar
• Deepika Pandhi SS, Sonthalia S. Human papilloma virus vaccines: current scenario. Indian J Sex Transm Dis. 2011;32(2):75–85. doi:10.4103/0253-7184.85409
   Google Scholar
• Drolet M, Bénard É, Pérez N; Study Group; Pollock K. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019;394(10197):497–509. doi:10.1016/S0140-6736(19)30298-3
   PubMed Web of Science ®Google Scholar
• Akhatova A, Azizan A, Atageldiyeva K, et al. Prophylactic human papillomavirus vaccination: from the origin to the current state. vaccines. 2022;10(11):1–21. doi:10.3390/vaccines10111912
   Web of Science ®Google Scholar
• Colzani E, Johansen K, Johnson H, Celentano LP. Human papillomavirus vaccination in the European Union / European Economic Area and globally: a moral dilemma. Eurosurveillance. 2021;26(50):1–9. doi:10.2807/1560-7917.ES.2021.26.50.2001659
   Web of Science ®Google Scholar
• Drolet M, Laprise J, Martin D, et al. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis. Lancet Infect Dis. 2021;21(1):21. doi:10.1016/S1473-3099(20)30947-6
   PubMedGoogle Scholar
• Harder T, Wichmann O, Klug SJ, et al. Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review. BMC Med. 2018;2:1–14.
   Google Scholar
• Hibbitts S, Cuschieri K. Should boys receive the HPV vaccine? Head to Head; 2010;340:5–6.
   Google Scholar
• Man I, Georges D, Sankaranarayanan R, Basu P, Baussano I. Building resilient cervical cancer prevention through gender- - neutral HPV vaccination. eLife. 2023;12:e85735. doi:10.7554/eLife.85735
   PubMedGoogle Scholar
• Bogaards JA, Wallinga J, Brakenhoff RH, Meijer CJLM, Berkhof J. Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis. BMJ. 2015;350(7):h2016–h2016. doi:10.1136/bmj.h2016
   PubMedGoogle Scholar
• World Health Organization. Human Papillomavirus Vaccines: WHO Position Paper. Vol. 2017. World Health Organization; 2017:241–268.
   Google Scholar
• World Health Organization. WHO guidance Note: comprehensive Cervical Cancer Prevention and Control: A Healthier Future for Girls and Women. World Health Organization. 2013;12.
   Google Scholar
• Rosado C, Fernandes ÂR, Lisboa C. Impact of human papillomavirus vaccination on male disease: a systematic review. Vaccine. 2023;3:1–19.
   Google Scholar
• Montoliu A, Brotons M, Alemany L, et al. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010 – 2019. Prev Med. 2021;3:144.
   Google Scholar
• Maria Grandahl TN, Burke MR, Sharma P, Excoffon KJDA, Kolawole AO. Barriers towards HPV vaccinations for boys and young men: a narrative review. Viruses. 2021;14(1):13. doi:10.3390/v14010013
   PubMedGoogle Scholar
• Shin H, Jeon S, Cho I, Park H. Factors affecting human papillomavirus vaccination in men: systematic review. JMIR Public Health Surveil. 2022;8(4):1–16. doi:10.2196/34070
   Google Scholar
• Gürsoy MY, Sağtaş F. Human papillomavirus vaccination in male university students in turkey: coverage rate, barriers, and associated factors. J Prev. 2023;44(2):181–191. doi:10.1007/s10935-022-00711-1
   Google Scholar
• Laserson AK, Oliffe JL, Krist J, Kelly MT. HPV vaccine and college-age men: a scoping review. Am J Men’s Health. 2020;14(6):1557988320973826. doi:10.1177/1557988320973826
   Web of Science ®Google Scholar
• World Health Organization (WHO). Immunization Agenda 2030: A Global Strategy to Leave No One Behind. Geneva: World Health Organization; 2020.
   Google Scholar